Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBT Margin (2016 - 2018)

Historic EBT Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to 326.71%.

  • Armata Pharmaceuticals' EBT Margin rose 120867100.0% to 326.71% in Q4 2018 from the same period last year, while for Dec 2018 it was 1015.24%, marking a year-over-year increase of 134100300.0%. This contributed to the annual value of 955.06% for FY2024, which is 32323600.0% up from last year.
  • As of Q4 2018, Armata Pharmaceuticals' EBT Margin stood at 326.71%, which was up 120867100.0% from 902.61% recorded in Q3 2018.
  • In the past 5 years, Armata Pharmaceuticals' EBT Margin ranged from a high of 1127.05% in Q2 2018 and a low of 45709.09% during Q4 2016
  • For the 5-year period, Armata Pharmaceuticals' EBT Margin averaged around 7578.34%, with its median value being 3710.89% (2014).
  • As far as peak fluctuations go, Armata Pharmaceuticals' EBT Margin surged by 732546900bps in 2014, and later tumbled by -434122200bps in 2016.
  • Armata Pharmaceuticals' EBT Margin (Quarter) stood at 2571.29% in 2014, then grew by 11bps to 2296.88% in 2015, then crashed by -1890bps to 45709.09% in 2016, then skyrocketed by 74bps to 11760.0% in 2017, then surged by 103bps to 326.71% in 2018.
  • Its EBT Margin stands at 326.71% for Q4 2018, versus 902.61% for Q3 2018 and 1127.05% for Q2 2018.